1. Levine SZ, Rotstein A, Kodesh A, Sandin S, Lee BK, Weinstein G, Schnaider Beeri M, Reichenberg, A. Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia. JAMA Netw Open. 2023;6(10):e2338088.
2. Travis-Lumer Y, Goldberg Y, Kodesh A, Reichenberg A, Sandin S, Frangou S, Levine SZ. Rates of Spontaneous Abortion in Israel Before and During the COVID-19 Pandemic. JAMA Netw Open. 2023;6(2):e230233-e230233.
3. Levine, SZ, Rotstein A, Goldberg Y, Reichenberg A, Kodesh A. (2023). Opioid Exposure and the Risk of Dementia: A National Cohort Study. Am J Geriatr Psychiatry. 2023;31(5):315-323.
4. Travis-Lumer Y, Kodesh A, Goldberg Y, Frangou S, Levine SZ. Attempted suicide rates before and during the COVID-19 pandemic: interrupted time series analysis of a nationally representative sample. Psychol Med. 2023;53(6):2485-2491.
5. Rotstein A, Fund S, Levine SZ, Reichenberg A, Goldenberg J. Is cognition integral to psychopathology? A population-based cohort study. Psychol Med. 2023;53(15):7350-7357.
6. Yin W, Norrback M, Levine SZ, et al. Maternal rheumatoid arthritis and risk of autism in the offspring. Psychol Med. 2023;53(15):7300-7308.
7. Leucht S, Dombi ZB, Szabo P, Barabassy A, Levine SZ. Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone. Schizophr Res. 2023;261:24-30.
8. Khachadourian V, Kodesh A, Levine SZ, et al. Somatic comorbidities of mental disorders in pregnancy. European psychiatry: the journal of the Association of European Psychiatrists. 2023;66(1):e15.
9. Samara MT, Levine SZ, Leucht S. Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials. Pharmacopsychiatry. 2023;56(1):18-24. https://doi.org/10.1055/a-1841-6672
10. Frangou S, Travis-Lumer Y, Kodesh A, Goldberg Y, New F, Reichenberg A, Levine SZ. Increased incident rates of antidepressant use during the COVID-19 pandemic: interrupted time-series analysis of a nationally representative sample. Psychol Med. 2023;53(11):4943-4951.
11. Travis-Lumer Y, Goldberg Y, Levine SZ. Effect size quantification for interrupted time series analysis: implementation in R and analysis for Covid-19 research. Emerging Themes in Epidemiology. 2022;19(1):9.
12. Eran-Jona, M., Tiargan-Orr, R., Levine, S. Z., Limor, Y., Schenhav, M., & Ben-Shalom, U. (2022). Habituation of Fear—Israeli-Jewish Population during Protracted Belligerence. International Journal of Environmental Research and Public Health, 19(23). https://doi.org/10.3390/ijerph192316067
13. Rotstein, A., Kodesh, A., Goldberg, Y., Reichenberg, A., & Levine, S. Z. (2022). Serum folate deficiency and the risks of dementia and all-cause mortality: a national study of old age. Evid Based Ment Health, 25(2), 63-68. doi:10.1136/ebmental-2021-300309
14. Levine, S. Z., Goldberg, Y., Yoshida, K., Samara, M., Cipriani, A., Iwatsubo, T., . . . Furukawa, T. A. (2022). Early- and subsequent- response of cognitive functioning in Alzheimer’s disease: Individual-participant data from five pivotal randomized clinical trials of donepezil. J Psychiatr Res, 148, 159-164. doi:10.1016/j.jpsychires.2022.01.055
15. Vancak, V., Goldberg, Y., & Levine, S. Z. (2022). The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application. Stat Med, 41(17), 3299-3320. https://doi.org/10.1002/sim.9418
16. Rotstein, A., Levine, S. Z., Samara, M., Yoshida, K., Goldberg, Y., Cipriani, A., . . . Furukawa, T. A. (2022). Cognitive impairment networks in Alzheimer’s disease: Analysis of three double-blind randomized, placebo-controlled, clinical trials of donepezil. Eur Neuropsychopharmacol, 57, 50-58. doi:10.1016/j.euroneuro.2022.01.001
17. Rotstein, A., Shadmi, E., Roe, D., Gelkopf, M., & Levine, S. Z. (2022). Gender differences in quality of life and the course of schizophrenia: a national study. BJPsych Open, 8(2), e35. doi:10.1192/bjo.2022.3
18. Travis-Lumer, Y., Kodesh, A., Goldberg, Y., Reichenberg, A., Frangou, S., & Levine, S. Z. (2022). Biopsychosocial exposure to the COVID-19 pandemic and the relative risk of schizophrenia: Interrupted time-series analysis of a nationally representative sample. Eur Psychiatry, 65(1), e7. doi:10.1192/j.eurpsy.2021.2245
19. Reichenberg, A., & Levine, S. Z. (2021). Primary challenges and practical solutions in preventive psychiatry. World Psychiatry, 20(2), 228-230. doi:10.1002/wps.20855
20. Levine, S. Z., Yoshida, K., Goldberg, Y., Samara, M., Cipriani, A., Efthimiou, O., Iwatsubo, T., Leucht, S., Furukawa, T. A. (2021). Linking the Mini-Mental State Examination, the Alzheimer’s Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil. Evid Based Ment Health, 24(2), 56-61. doi:10.1136/ebmental-2020-300184
21. Levine, S. Z., Goldberg, Y., Yoshida, K., Samara, M., Cipriani, A., Iwatsubo, T., Leucht., Z., Furawaka, T. A. (2021). Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil. Eur Psychiatry, 64(1), e16. doi:10.1192/j.eurpsy.2021.8
22. Samara, M., Levine, S. Z., Yoshida, K., Goldberg, Y., Cipriani, A., Efthimiou, O., . . . Furakawa, T. A. (2021). Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician’s Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence-based on Individual Participant Data from Five Randomized Clinical Trials of Donepezil. J Alzheimers Dis, 82(3), 1075-1084
23. Vancak, V., Goldberg, Y., & Levine, S. Z. (2021). Guidelines to understand and compute the number needed to treat. Evid Based Ment Health, 24(4), 131-136. doi:10.1136/ebmental-2020-300232
24. Rotstein, A., & Levine, S. Z. (2021). Childhood infectious diseases and old age cognitive functioning: a nationally representative sample of community-dwelling older adults. Int Psychogeriatr, 33(1), 75-82. doi:10.1017/S1041610220001404
25. *Furukawa, T. A., *Levine, S. Z., Buntrock, C., Ebert, D. D., Gilbody, S., Brabyn, S., . . . Karyotaki, E. (2021). How can we estimate QALYs based on PHQ-9 scores? Equipercentile linking analysis of PHQ-9 and EQ-5D. Evid Based Ment Health, 24(3), 97-101. doi:10.1136/ebmental-2020-300240 (*Joint contribution)
26. Furukawa, T. A., Levine, S. Z., Buntrock, C., & Cuijpers, P. (2021). Increasing the clinical interpretability of PHQ-9 through equipercentile linking with health utility values by EQ-5D-3L. Evid Based Ment Health. doi:10.1136/ebmental-2021-300299
27. Khatib, A., Ben-David, V., Gelkopf, M., & Levine, S. Z. (2021). Ethnic group and social support contribution to posttraumatic growth after sudden spousal loss among Jewish, Muslim, and Druze widows in Israel. J Community Psychol, 49(5), 1010-1023. doi:10.1002/jcop.22565
28. Kodesh, A., Levine, S. Z., Khachadourian, V., Rahman, R., Schlessinger, A., O’Reilly, P. F., . . . Janecka, M. (2021). Maternal health around pregnancy and autism risk: a diagnosis-wide, population-based study. Psychol Med, 1-9. doi:10.1017/S0033291721001021
29. Pereira, G., Francis, R. W., Gissler, M., Hansen, S. N., Kodesh, A., Leonard, H., Levine, S. Z., Mitter, V. R., Parner, E. T., Regan, A. K., Reichenberg, A., Sandin, S., Suominen, A., Schendel, D. (2021). Optimal interpregnancy interval in autism spectrum disorder: A multi-national study of a modifiable risk factor. Autism Research, 14(11), 2432-2443. doi:10.1002/aur.2599
30. Rotstein, A., Goldenberg, J., Fund, S., Levine, S. Z., & Reichenberg, A. (2021). Capturing adolescents in need of psychiatric care with psychopathological symptoms: A population-based cohort study. European Psychiatry, 64(1), e76. https://doi.org/10.1192/j.eurpsy.2021.2251
31. Weinstein, Y., Gelkopf, M., Roe, D., & Levine, S. Z. (2021). Terror exposure and psychiatric rehabilitation utilization: A national study of Jewish citizens in Israel. Israel Journal of Psychiatry and Related Sciences, 58(1), 1-20.
32. Pijnenburg, L. J., de Haan, L., Smith, L., Rabinowitz, J., Levine, S. Z., Reichenberg, A., & Velthorst, E. (2021). Early predictors of mental health in mid-adulthood. Early Interv Psychiatry, 15(1), 158-166. doi:10.1111/eip.12924
33. Kodesh, A., Goldberg, Y., Rotstein, A., Weinstein, G., Reichenberg, A., Sandin, S., & Levine, S. Z. (2020). Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study. Schizophr Res, 223, 220-226. doi:10.1016/j.schres.2020.07.020
34. Kan, K. J., de Jonge, H., van der Maas, H. L. J., Levine, S. Z., & Epskamp, S. (2020). How to Compare Psychometric Factor and Network Models. J Intell, 8(4). doi:10.3390/jintelligence8040035
35. Vancak, V., Goldberg, Y., & Levine, S. Z. (2020). Systematic analysis of the number needed to treat. Stat Methods Med Res, 29(9), 2393-2410. [R package developed: https://github.com/vancak/NNTcalculator]
36. Kodesh, A., Sandin, S., Reichenberg, A., Rotstein, A., Pedersen, N. L., Ericsson, M., Karlsson, I. K., Davidson, M.. Levine, S. Z. (2020). Antidepressants and the Risk of Dementia: Appropriate Consideration of Confounding by Indication. Am J Geriatr Psychiatry, 28(4), 499-500.
37. Rahman, R., Kodesh, A., Levine, S. Z., Sandin, S., Reichenberg, A., & Schlessinger, A. (2020). Identification of newborns at risk for autism using electronic medical records and machine learning. Eur Psychiatry, 63(1), e22.
38. Dinstein, I., et al. (2020). The National Autism Database of Israel: a Resource for Studying Autism Risk Factors, Biomarkers, Outcome Measures, and Treatment Efficacy. J Mol Neurosci, 70(9), 1303-1312.
39. Kodesh, A., Sandin, S., Reichenberg, A., Rotstein, A., Pedersen, N. L., Ericsson, M., Karlsson, I. K., Davidson, M., & Levine, S. Z. (2019). Exposure to antidepressant medication and the risk of incident dementia. American Journal of Geriatric Psychiatry, 27(11):1177-1188.
40. Kan, K.-J., van der Maas, H. L. J., & Levine, S. Z. (2019). Extending psychometric network analysis: Empirical evidence against g in favor of mutualism? Intelligence, 73, 52-62.
41. Bai D, Yip BHK, Windham GC, Sourander A, Francis R, Yoffe R, Glasson E, Mahjani B, Suominen A, Leonard H, Gissler M, Buxbaum JD, Wong K, Schendel D, Kodesh A, Breshnahan M, Levine SZ, Parner ET, Hansen SN, Hultman C, Reichenberg A, Sandin S. (2019). Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort. JAMA Psychiatry, 76(10):1035–1043.
42. Hansen, S. N., Schendel, D. E., Francis, R. W., Windham, G. C., Bresnahan, M., Levine, S. Z., et al. (2019). Recurrence Risk of Autism in Siblings and Cousins: A Multinational, Population-Based Study. J Am Acad Child Adolesc Psychiatry, 58(9), 866-875.
43. Kodesh, A., Levav, I., & Levine, S. Z. (2019). Exposure to Genocide and the Risk of Dementia. J Trauma Stress, 32(4), 536-545.
44. Noma, H., Maruo, K., Gosho, M., Levine, S. Z., Goldberg, Y., Leucht, S., et al. (2019). Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models. [journal article]. BMC Med Res Methodol, 19(1), 33.
45. Rabinovitz, S., Goldman, K., Rosca, P., Barda, J., & Levine, S. Z. (2019). The role of substance use and adult sexual assault severity in the course of schizophrenia: An epidemiological catchment study of sexual assault victims. Schizophr Res, 208, 406-413.
46. Vinokur, D., & Levine, S. Z. (2019). Non-suicidal self-harm in prison: A national population-based study. Psychiatry Res, 272, 216-221.
47. Levine, S. Z., Kodesh, A., Viktorin, A., Smith, L., Uher, R., Reichenberg, A., & Sandin, S. Association of Maternal Use of Folic Acid and Multivitamin Supplements in the Periods Before and During Pregnancy With the Risk of Autism Spectrum Disorder in Offspring. JAMA Psychiatry, 75(2), 176-184. doi:10.1001/jamapsychiatry.2017.4050
48. Janecka, M., Kodesh, A., Levine, S. Z., Lusskin, S. I., Viktorin, A., Rahman, R., et al. (2018). Association of Autism Spectrum Disorder With Prenatal Exposure to Medication Affecting Neurotransmitter Systems. JAMA Psychiatry, 75(12), 1217-1224.
49. Leucht, S., Levine, S. Z., Samara, M., Cipriani, A., Davis, J. M., & Furukawa, T. A. (2018). Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why? Eur Arch Psychiatry Clin Neurosci.
50. Davidovitch, M., Chodick, G., Shalev, V., Eisenberg, V. H., Dan, U., Reichenberg, A., Sandin, S., Levine, S. Z. (2018). Infertility treatments during pregnancy and the risk of autism spectrum disorder in the offspring. Prog Neuropsychopharmacol Biol Psychiatry, 86, 175-179.
51. Viktorin, A., Levine, S. Z., Altemus, M., Reichenberg, A., & Sandin, S. (2018). Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study. BMJ, 361, k2233.
52. Rotstein, A., Roe, D., Gelkopf, M., & Levine, S. Z. (2018). Age of onset and quality of life among males and females with schizophrenia: A national study. Eur Psychiatry, 53, 100-106.
53. Furukawa, T. A., Maruo, K., Noma, H., Tanaka, S., Imai, H., Shinohara, K., Ikeda, K., Yamawaki, S., Levine, S Z., Goldberg, Y., Leucht, S., Cipriani, A. (2018). Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis. Acta Psychiatr Scand, 137(6), 450-458.
54. Smith, L., Reichenberg, A., Rabinowitz, J., Levine, S. Z., & Velthorst, E. (2018). Psychiatric symptoms and related dysfunction in a general population sample. Schizophrenia Research: Cognition, 14, 1-6.
55. Rotstein A., Roe D., Gelkopf M., Shadmi E. & Levine S.Z. (2018). Quality of life disparities between persons with schizophrenia and their professional caregivers: Network analysis in a national cohort. Schizophrenia Research, 197, 109-115
56. Weinstein, Y., Levav, I., Gelkopf, M., Roe, D., Yoffe, R., Pugachova, I. & Levine, S. Z. (2018). Association of maternal exposure to terror attacks during pregnancy and the risk of schizophrenia in the offspring: A population-based study. Schizophr Res, 199, 163-167. doi:10.1016/j.schres.2018.04.024
57. Samara, M. T., Goldberg, Y., Levine, S. Z., Furukawa, T. A., Geddes, J. R., Cipriani, A., et al. (2017). Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies. Lancet Psychiatry, 4(11), 859-867
58. Viktorin, A., Uher, R., Kolevzon, A., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017). Association of antidepressant medication use during pregnancy with intellectual disability in offspring. JAMA Psychiatry, 74(10), 1031-1038.
59. Viktorin, A., Uher, R., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017). Autism risk following antidepressant medication during pregnancy. Psychol Med, 47(16), 2787-2796.
60. Weinstein, Y., Gelkopf, M., Roe, D., Levine, S.Z., 2017. The effect of different terror exposures on the course of schizophrenia: A twenty-year follow-up of a random sample. Schizophr Res 189, 215-216.
61. Weiser, M., Levi, L., Levine, S.Z., Bialer, M., Shekh-Ahmad, T., Matei, V., Tiugan, A., Cirjaliu, D., Sava, C., Sinita, E., Zamora, D., Davis, J.M. (2017). A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania. Bipolar Disorders 19, 285-294.
62. Bursztein Lipsicas, C., Levav, I., & Levine, S. Z. (2017). Holocaust exposure and subsequent suicide risk: a population-based study. Social Psychiatry and Psychiatric Epidemiology, 52, 311-317.
63. Levine, S. Z., & Leucht, S. (2016). Identifying a system of predominant negative symptoms: Network analysis of three randomized clinical trials. Schizophrenia Research, 178, 17-22.
64. Madhoo, M., & Levine, S. Z. (2016). Network analysis of the Quick Inventory of Depressive Symptomatology: Reanalysis of the STAR*D clinical trial. Eur Neuropsychopharmacol, 26, 1768-1774.
65. Levine, S. Z., Levav, I., Pugachova, I., Yoffe, R., & Becher, Y. (2016). Transgenerational effects of genocide exposure on the risk and course of schizophrenia: A population-based study. Schizophrenia Research, 176, 540-545.
66. Gelkopf, M., Lapid, L., Werbeloff, N., Levine, S. Z., Telem, A., Zisman-Ilani, Y., & Roe, D. (2016). A strengths-based case management service for people with serious mental illness in Israel: A randomized controlled trial. Psychiatry Res, 241, 182-189.
67. Levine, S. Z., Levav, I., Yoffe, R., Becher, Y., & Pugachova, I. (2016). Genocide Exposure and Subsequent Suicide Risk: A Population-Based Study. PLoS One, 11, e0149524. doi:10.1371/journal.pone.0149524.
68. Levine, S. Z., Kodesh, A., Goldberg, Y., Reichenberg, A., Furukawa, T. A., Kolevzon, A., & Leucht, S. (2016). Initial severity and efficacy of risperidone in autism: Results from the RUPP trial. European Psychiatry, 32, 16-20.
69. Levine, S. Z., Levav, I., Goldberg, Y., Pugachova, I., Becher, Y., & Yoffe, R. (2016). Exposure to genocide and the risk of schizophrenia: a population-based study. Psychological Medicine, 46, 855-863.
70. Velthorst, E., Reichenberg, A., Rabinowitz, J., & Levine, S. Z. (2015). Study of resilience and environmental adversity in midlife health (STREAM). Social Psychiatry and Psychiatric Epidemiology, 50, 1915-1922.
71. Levine, S. Z., Rabinowitz, J., Uher, R., & Kapur, S. (2015). Biomarkers of treatment outcome in schizophrenia: Defining a benchmark for clinical significance. European Neuropsychopharmacology, 25, 1578-1585.
72. Madhoo, M., & Levine, S. Z. (2015). Initial Severity Effects on Residual Symptoms in Response and Remission: A STAR*D Study During and After Failed Citalopram Treatment. Journal of Clinical Psychopharmacology, 35, 450-453.
73. Levine, S. Z., Goldberg, Y., Samara, M., Davis, J. M., & Leucht, S. (2015). Joint modeling of dropout and outcome in three pivotal clinical trials of schizophrenia. Schizophrenia Research, 164, 122-126.
74. Wilson, J. E., Niu, K., Nicolson, S. E., Levine, S. Z., & Heckers, S. (2015). The diagnostic criteria and structure of catatonia. Schizophrenia Research, 164, 256-262.
75. Furukawa, T. A., Levine, S. Z., Tanaka, S., Goldberg, Y., Samara, M., Davis, J. M., Cipriani, A., Leucht, S. (2015). Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry, 72, 14-21. Joint first author.
76. Levine, S. Z., Levav, I., Yoffe, R., & Pugachova, I. (2014). The Effects of Pre-natal-, Early-Life- and Indirectly- Initiated Exposures to Maximum Adversities on the Course of Schizophrenia. Schizophrenia Research, 236-240.
77. Levine, S. Z., Goldberg, Y., Yoffe, R., Pugachova, I., & Reichenberg, A. (2014). Suicide attempts in a national population of twins concordant for psychoses. European Neuropsychopharmacology, 24, 1203-1209.
78. Levine, S. Z., & Leucht, S. (2014). Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials. Schizophrenia Research, 156, 107-114.
79. Marques, T. R., Levine, S. Z., Reichenberg, A., Kahn, R., Derks, E. M., Fleischhacker, W. W., Rabinowitz, J., & Kapur, S. (2014). How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses. European Neuropsychopharmacology, 24, 1279-1288.
80. Yonai, S., Levine, S., Z., & Glicksohn, J. (2015). Trajectories of crime and familial characteristics: a longitudinal national population-based study. Crime and Delinquency, 61, 927–949.
81. Levine, S. Z. (2014). Low birth-weight and risk for major depression: A community-based longitudinal study. Psychiatry Research, 215, 618-623.
82. Russo, M., Levine, S. Z., Demjaha, A., DiForti, M., Bonaccorso, S., Fearon, P., Dazzan, P., Pariante, C M., David, A.S., Morgan, C., Murray, R. M., Reichenberg, A. (2014). The Association between Symptom Dimensions and Categorical Diagnoses of Psychosis: A Cross Sectional and Longitudinal Investigation. Schizophrenia Bulletin, 40, 111-119.
83. Vinokurov, D., Levine, S. Z., Roe, D., Krivoy, A., & Fischel, T. (2014). Age of onset group characteristics in forensic patients with schizophrenia. European Psychiatry, 29, 149-152. (IF= 3.123).
84. Bensimon, M., Levine, S. Z., Zerach, G., Stein, E., Svetlicky, V., & Solomon, Z. (2013). Elaboration on posttraumatic stress disorder diagnostic criteria: A factor analytic study of PTSD exposure to war or terror. Israeli Journal of Psychiatry, 50, 84-90.
85. Furnham, A., Guenole, N., Levine, S. Z., & Chamorro-Premuzic, T. (2013). The NEO Personality Inventory–Revised: Factor structure and gender invariance from exploratory structural equation modeling analyses in a High-Stakes Setting. Assessment, 20, 14-23.
86. Garber-Epstein, P., Zisman-Ilani, Y., Levine, S. Z., Roe, D. (2013). Comparative Impact of Professional Mental Health Background on Ratings of Consumer Outcome and Fidelity in an Illness Management and Recovery Program. Psychiatric Rehabilitation Journal, 36, 236-242.
87. Levine, S. Z. (2013). Evaluating the seven-item Center for Epidemiologic Studies Depression Scale Short-Form: A longitudinal US community study. Social Psychiatry and Psychiatric Epidemiology, 48, 1519-1526.
88. Levine, S. Z., & Leucht, S. (2013). Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms. Schizophrenia Research, 145, 125-127.
89. Levine, S. Z., & Leucht, S. (2013). Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms. European Neuropsychopharmacology, 23, 1051-1056.
90. Levine, S. Z., & Leucht. (2013). Attaining and sustaining remission of predominant negative symptoms. Schizophrenia Research, 143, 60-64.
91. Levine, S. Z., Rabinowitz, J., Ascher-Svanum, H., Faries, D. E., & Lawson, A. H. (2013). Comparing Symptom Response among Antipsychotic Medications in CATIE. Journal of Clinical Psychopharmacology, 123-126.
92. Velthorst, E., Levine, S. Z., Henquet, C., de Haan, L., van Os, J., Myin-Germeys, I., & Reichenberg, A. (2013). To cut a short test even shorter: Reliability and validity of a brief assessment of intellectual ability in Schizophrenia-a control-case family study. Cognitive Neuropsychiatry, 18, 574-593.
93. Yonai, S., Levine, S. Z., & Glicksohn, J. (2013). A national population based examination of the association between age-versatility trajectories and recidivism rates. Journal of Criminal Justice, 41, 467-476.
94. Yonai, S., Levine, S. Z., & Glicksohn, J. (2013). Elaboration on specialization in crime: Disaggregating age-cohort effects. Crime and Delinquency 59, 951-970.
95. Levine, S. Z., & Leucht, S. (2012). Delayed- and Early- Onset Hypotheses of Antipsychotic Drug Action in the Negative Symptoms of Schizophrenia. European Neuropsychopharmacology, 22, 812-817.
96. Levine, S. Z., & Leucht, S. (2012). Early Symptom Response to Antipsychotic Medication as a Marker of Subsequent Symptom Change: An Eighteen-Month Follow-Up Study of Recent Episode Schizophrenia. Schizophrenia Research, 141, 168-172.
97. Levine, S.Z., Rabinowitz, J., Faries, D., Lawson, A.H., Ascher-Svanum, H. (2012). Treatment response trajectories and antipsychotic medications: Examination of up to18 months of treatment in the CATIE chronic schizophrenia trial. Schizophrenia Research, 137, 141-146.
98. Rabinowitz, J., Levine, S. Z., Garibaldi, G., Bugarski-Kirola, D., Berardo, CG, Kapur, S. (2012). Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia. Schizophrenia Research, 137, 147-150.
99. Ullman, V. Z., Levine, S. Z., Reichenberg, A., & Rabinowitz, J., (2012). Real-world premorbid functioning in schizophrenia and affective disorders during the early teenage years: A population-based study of school grades and teacher ratings. Schizophrenia Research, 136, 13-18.
100. Walsh, S. D., Levine, S. Z., & Levav, I. (2012). The association between depression and parental ethnic affiliation and socioeconomic status: A 27-year longitudinal US community study. Social Psychiatry and Psychiatric Epidemiology, 47, 1153-1158.
101. Werbeloff, N., Levine, S. Z., & Rabinowitz, J. (2012). Elaboration on the association between immigration and schizophrenia: A population-based national study disaggregating annual trends, country of origin and sex over 15 years. Social Psychiatry and Psychiatric Epidemiology, 47, 303-311.
102. Baloush-Kleinman, V., Levine, S. Z., Roe, D., Shnitt, D., Weizman, A., & Poyurovsky, M. (2011). Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Schizophrenia Research, 130, 176-181.
103. Hultman, C. M., Sandin, S., Levine, S. Z., Lichtenstein, P., & Reichenberg, A. (2011). Advancing paternal age and risk of autism: New evidence from a population-based study and a meta-analysis of epidemiological studies. Molecular Psychiatry, 16, 1203-1212.
104. Levine, S. Z. (2011). Elaboration on the association between IQ and parental SES with subsequent crime. Personality and Individual Differences, 50, 1233-1237.
105. Levine, S. Z., Lurie, I., Kohn, R., & Levav, I. (2011). Trajectories of the course of schizophrenia: From progressive deterioration to amelioration over three decades. Schizophrenia Research, 126, 184-191.
106. Levine, S. Z., Rabinowitz, J., & Rizopoulos, D. (2011). Recommendations to improve the Positive and Negative Syndrome Scale (PANSS) based on item response theory. Psychiatry Research, 188, 446-452.
107. Levine, S. Z., Rabinowitz, J., Ascher-Svanum, H., Faries, D. E., & Lawson, A. H. (2011). Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study. Schizophrenia Research, 133, 42-46.
108. Laufer, A., Solomon, Z., & Levine, S. Z. (2010). Elaboration on posttraumatic growth in youth exposed to terror: The role of religiosity and political ideology. Social Psychiatry and Psychiatric Epidemiology, 45, 647-653.
109. Levine, S. Z., & Leucht, S. (2010). Elaboration on the early-onset hypothesis of antipsychotic drug action: Treatment response trajectories. Biological Psychiatry, 68, 86-92.
110. Levine, S. Z., & Rabinowitz, J. (2010). Trajectories and antecedents of treatment response over time in early-episode psychosis. Schizophrenia Bulletin, 36, 624-632.
111. Levine, S. Z., Bakst, S., & Rabinowitz, J. (2010). Suicide attempts at the time of first admission and during early course schizophrenia: A population-based study. Psychiatry Research, 177, 55-59.
112. Levine, S. Z., Rabinowitz, J., Case, M., & Ascher-Svanum, H. (2010). Treatment response trajectories and their antecedents in recent-onset psychosis: A two-year prospective study. Journal of Clinical Psychopharmacology, 30, 441-445.
113. Lurie, I., & Levine, S. Z. (2010). Meta-Analysis of dropout rates in SSRIs Versus placebo in randomized clinical trials of PTSD. Journal of Nervous and Mental Disease, 198, 116-124.
114. Mansbach-Kleinfeld, I., Apter, A., Farbstein, I., Levine, S. Z, & Poznizovsky, A. (2010). A population-based psychometric validation study of the Strengths and Difficulties Questionnaire - Hebrew version. Frontiers in Psychiatry 1, (151), 1-12.
115. Rabinowitz, J., Levine, S. Z., & Martinez, G. (2010). Concordance between measures of functioning, symptomatology and change: GAF, CGI-S, CGI-C and PANSS. Journal of Clinical Psychopharmacology, 30, 478-480.
116. Laufer, A., Raz-Hamama, Y., Levine, S. Z., & Solomon, Z. (2009). Posttraumatic growth in adolescence: The role of religiosity, distress and forgiveness. Journal of Social and Clinical Psychology, 28, 862-880.
117. Brill, N., Levine, S. Z., Reichenberg, A., Lubin, G., Weiser, M., & Rabinowitz, J. (2009). Pathways to functional outcomes in schizophrenia: The role of premorbid functioning, negative symptoms and intelligence. Schizophrenia Research, 110, 40-46.
118. Levine, S. Z. (2009). Examining the incidence of and time to recidivism within the risk contingency framework: A 20 year follow-up study. Law and Human Behavior, 33, 167-174.
119. Levine, S. Z., & Rabinowitz, J. (2009). A population based examination of the role of years of education, age of onset and sex on the course of schizophrenia. Psychiatry Research, 168, 11-17.
120. Levine, S., Z., Laufer, A., Stein, E., Hamama-Raz, Y., & Solomon, Z. (2009). Examining the relationship between resilience and posttraumatic growth. Journal of Traumatic Stress, 22, 282–286.
121. Rabinowitz, J., Levine, S. Z., Barkai, O., & Davidov, O. (2009). Dropout rates in randomized clinical trials of antipsychotics: A meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features. Schizophrenia Bulletin, 35, 775–788. (IF= 7.575).
122. Levine, S. Z. (2008). Population-based examination of the relationship between type of first admission for schizophrenia and outcomes. Psychiatric Services, 59, 1470-1473.
123. Levine, S. Z. (2008). Using intelligence to predict subsequent contacts with the criminal justice system for sex offenses. Personality and Individual Differences, 44, 453-463.
124. Levine, S. Z., Laufer, A., Hamama-Raz, Y., Stein, E., & Solomon, Z. (2008). Posttraumatic growth in adolescence: Examining its components and relationship with PTSD. Journal of Traumatic Stress, 21, 492-496.
125. Levine, S. Z., Rabinowitz, J., Engel, R., Etschel, E., & Leucht, S. (2008). Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI. Schizophrenia Research, 98, 318-322.
126. Rabinowitz, J., Levine, S. Z., Medori, R., Oosthuizen, P., Koen, L., & Emsley, R. (2008). Concordance of patient and clinical ratings of symptom severity and change of psychotic illness. Schizophrenia Research, 100, 359-360.
127. Levine, S. Z., & Rabinowitz, J. (2007). Revisiting the 5 dimensions of the positive and negative syndrome scale. Journal of Clinical Psychopharmacology, 27, 431-436.
128. Rabinowitz, J., Levine, S. Z., Brill, N., & Bromet, E. J. (2007). The Premorbid Adjustment Scale Structured Interview (PAS-SI): Preliminary findings. Schizophrenia Research, 90, 255-257.
129. Rabinowitz, J., Levine, S. Z., Haim, R., & Häfner, H. (2007). The course of schizophrenia: progressive deterioration, amelioration or both? Schizophrenia Research, 91, 254-258.
130. Rabinowitz, J., Levine, S. Z., & Häfner, H. (2006). A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophrenia Research, 88, 96-101.
131. Levine, S. Z., Petrides, K. V., Davis, S., Jackson, C. J., & Howell, P. (2005). The use of structural equation modeling in stuttering research: concepts and directions. Stammering Research, 4, 344-363.
132. Levine, S. Z., & Jackson, C. J. (2004). Eysenck’s theory of crime revisited: Factors or primary scales? Legal and Criminological Psychology, 9, 135-152.
133. Jackson, C., Levine, S. Z., & Furnham, A. (2003). Gray’s model of personality and aggregate level factor analysis. European Journal of Personality, 17, 397-411.
134. Petrides, K. V., Furnham, A., Jackson, C. J., & Levine, S. Z. (2003). Exploring issues of personality measurement and structure through the development of a revised short form of the Eysenck Personality Profiler. Journal of Personality Assessment, 81, 272-281.
135. Jackson, C. J., Levine, S. Z., Furnham, A., & Burr, N. (2002). Predictors of cheating behavior at university: A lesson from the psychology of work. Journal of Applied Social Psychology, 32, 1031-1046.
136. Levine, S. Z., & Jackson, C. J. (2002). Aggregated personality, climate and demographic factors as predictors of departmental shrinkage. Journal of Business and Psychology, 17, 287-297.
Book Chapters
1. Sandin S, Kolevzon A, Levine SZ, Hultman CM, Reichenberg A. (2012). Parental and Perinatal Risk Factors for Autism: Epidemiological Findings and Potential Mechanisms. In J. D. Buxbaum & P. R. Hof (Eds.), The Neuroscience of Autism Spectrum Disorders. San Diego: Academic Press.
2. *Yonai, S., Ashira, Z., & Levine, S. Z. (2009). Creating a deterrence effect by DNA testing among criminals The Fundamentals of Research 2009: Research and Literature Reviews of the Activities of the Israeli Police Force. A Collection of Articles. Jerusalem: Israeli Police Force (In Hebrew).
3. *Ziv, N., Levine, S. Z., & *Yonai, S. (2009). The effect of geographical distance from the war-zone on the crime rate. The Fundamentals of Research 2009: Research and Literature Reviews of the Activities of the Israeli Police Force. A Collection of Articles. Jerusalem: Israeli Police Force (In Hebrew).
4. Werner, S., Levine, S. Z., & Rabinowitz, J. (2008). The course of schizophrenia: The natural course of schizophrenia: progressive deterioration, amelioration or both? In Y. Teller (Ed.), Upwards: Chapters in Community Mental Health. Haifa: Ahvah Publishers (In Hebrew).
5. Rabinowitz, J., & Levine, S. Z. (2007). Epidemiología de la esquizofrenia: inicio y curso: Elsevier-Masson. In J. L.Vázquez-Barquero & B. Crespo-Facorro (Eds.), Nuevos enfoques para la intervención en primeros episodios de psicosis. Milan: Elsevier Masson (In Spanish).
6. Petrides, K. V., Jackson, C. J., Furnham, A., & Levine, S. Z. (2004). Development of a Short Form of the Eysenck Personality Profiler via Structural Equation Modelling. In K. van Monford, J. Oud & A. Satorra (Eds.), Recent developments in structural equation modeling: Theory and applications. Dordrecht: Kluwer Academic Publishers.
Levine, S. Z. (2007). Handbook of multimethod measurement in psychology. Washington DC: APA. By M. Eid & E. Deiner (Eds.). British Journal of Mathematical and Statistical Psychology, 60, 194-196.
Levine SZ, Travis-Lumer Y, Kodesh A, Goldberg Y, Reichenberg A, Frangou S. Attempted suicide rates before and during the COVID-19 pandemic: interrupted time series analysis of a nationally representative sample. Paper presented at: 20th Congress of the European Psychiatric Association Section of Epidemiology and Social Psychiatry; 8-10 September, 2022; Cambridge, UK.
Rotstein A, Levine SZ, Samara M, et al. Unknown Treatment Effects of Donepezil in Alzheimer’s Disease: Network Analysis of Three Double-Blind Randomized, Placebo-Controlled, Clinical Trials. Paper presented at: Alzheimer’s Association International Conference2022.
Levine SZ, Weinstein G, Rotstein A, et al. Late-Onset Schizophrenia and the Competing Risks of Dementia and Death: A National Cohort Study. Paper presented at: 2022 Alzheimer’s Association International Conference2021.
Khachadourian V, Zatorski N, Rahman R, et al. Maternal Medications in Pregnancy and Risk of Autism in the Offspring. Paper presented at: NEUROPSYCHOPHARMACOLOGY 2021.
Khachadourian V, Kodesh A, Levine S, et al. Maternal Psychiatric Diagnosis and Comorbidities Around Pregnancy. Biological Psychiatry; 2021.
Janecka, M., Kodesh, A., Levine, SZ., Schendel, D. E., Buxbaum, J. D., Sandin, S., & Reichenberg, A. (2020). The Etiological Relationships between Maternal Health and Autism Spectrum Disorder. Paper presented at the International Society for Autism Research (INSAR) 2020 Virtual Meeting.
Levine, SZ. (2019). Prenatal exposures and autism risk in the offspring. Guest speaker at the National Autism Conference, Ben Gurion University, Israel.
Kodesh, A., Herkovitz, P., Levine, SZ. (2018). Prevalence and comorbidities of dementia in Israel: A nationally representative study. The Annual Conference of the ISQ- Israel Society for Quality. November 20-21, 2018. David Intercontinental Hotel, Tel Aviv, Israel.
Reichenberg, A., Janecka, M., Sandin, S., Rahman, R., Lusskin, S., Viktorin, A., Levine, SZ., Kodesh, A. (2018). T94. Autism Risk After Prenatal Exposure to Medication Affecting Neurotransmitter Systems. Paper presented at the American College of Neuropsychopharmacology (ACNP) 57th Annual Meeting, Florida, US.
Levine, S. Z., & Leucht, S. (2017) Network Analysis of the SANS: Analysis of Three Randomized Clinical Trials of Predominant Negative Symptoms. The 15th International Congress for Schizophrenia Research, San Diego, US
Levine, S. Z., & Leucht, S. (2016). Toward a Negative symptom system of Schizophrenia: A network approach. The Fifth Biannual Schizophrenia International Research Society Conference. Florence, Italy.
Levine, S. Z., Goldberg, Y., Samara, M., Davis, J., & Leucht, S. (2016). Joint modeling of dropout and outcome in three pivotal clinical trials of schizophrenia. The Fifth Biannual Schizophrenia International Research Society Conference. Florence, Italy.
Kodesh, A., Levine, S.Z., Valinsky, L., Hershkowitz-Sikron, F. (2016). The course of diabetes in schizophrenia: An epidemiological study. The Fifth Biannual Schizophrenia International Research Society Conference. Florence, Italy.
Levine, S. Z., Furukawa, T, Tanaka, S., Goldberg, Y., Samara, M., Davis, J., Cipriani A., Leucht S. (2015). Initial severity in the treatment of schizophrenia. Talk at: Fourth International Congress on Schizophrenia Research, Spring Falls, USA.
Niu, K., Wilson, J., Heckers, S., & Levine, S.Z (2014, February 15 – 18). Psychometric Properties of the Bush Francis Catatonia Rating Scale. Paper presented at the Journal of Neuropsychiatry and Clinical Neurosciences, Washington DC, USA.
Levine, S. Z., Kolevzon, A., & Reichenberg. (2014). Past and Future Trends of Clinical Trials for Autism Spectrum Disorders. Paper presented at the International Society for CNS Clinical Trials and Methodology 2014 Autumn Conference. Washington DC, USA.
Levine, S. Z., Rabinowitz, J., Caers, I., Mandel, F., Menard, F., Kapur, S. (2013). Item Response Theory analysis of the PANSS from the NewMeds repository from 49 RCTs. Talk presented at the 14th International Congress for Schizophrenia Research, Orlando, US.
Levine, S. Z., Ascher-Svanum, H., Faries, D. E., Lawson, A. H., & Rabinowitz, J. (2012). Comparing Symptom Response among Antipsychotic Medications in CATIE. Paper presented at the 3rd Biennial Schizophrenia International Research Conference, Florence, Italy.
Levine, S. Z. and S. Leucht (2012). What does the SANS mean? Paper presented at the International Society for CNS Clinical Trials and Methodology 2012 Autumn Conference. Marina del Rey, USA.
Levine, S. Z., Yoffe, R., Pugachova, I., & Reichenberg, A. (2012). Familial and genetic factors in the trajectories of the course of serious mental illness: A national population-based twin study. Paper presented at the 3rd Biennial Schizophrenia International Research Conference, Florence, Italy.
Davidson, M., Reichenberg, A., Levine, S. Z., Rabinowitz, J., Keefe, R., Murray, R., Moffitt, T., & Caspi, A. (2011). Modeling the expression and course of developmental abnormalities preceding adult schizophrenia: characterization of a new developmental ultra-high-risk group in 2 birth cohorts. Paper presented at the 13th International Congress on Schizophrenia Research, Colorado Springs, USA.
Levine, S. Z., Rabinowitz J, Ascher-Svanum H, Faries, D. E., Lawson A. H. (2011). Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study. Poster presented at the ISPOR 14th Annual European Congress Madrid, Spain.
Levine, S. Z., Rabinowitz J, Ascher-Svanum H, Faries, D. E., Lawson A. H. (2011). Treatment Response Trajectories and Antipsychotic Medication in the Treatment of Chronic Schizophrenia. The 164th Annual Meeting of the American Psychiatric Association, Honolulu, Hawaii.
Rabinowitz, J., Garibaldi, G., Levine, S. Z., Bugarski-Kirola, D., Berardo C., Kapur S. (2011). Negative symptoms have greater impact on functioning than positive sympoms in schizophrenia: Analysis of the CATIE data. Poster presented at the ISPOR 14th Annual European Congress Madrid, Spain.
Russo, M., Levine, S. Z., Demjaha, A., Di Forti, M., Mondelli, V., Belvederi-Murri, M., Wiffen, B., Dazzan, P., Fearon, P., Morgan, C., Murray, R., Reichenberg, A. (2011). The hierarchical organization of symptom dimensions in first episode psychosis and the relationship to diagnostic classification. The 13th International Congress on Schizophrenia Research, Colorado Springs, USA.
Levine, S. Z., Bakst, S., & Rabinowitz, J. (2010). Suicide Attempts at the time of First admission and during Early Course Schizophrenia: A Population Based Study. The Second Schizophrenia International Research Society Conference. Italy.
Rabinowitz, J., Levine, S. Z., & Martinez, G. (2010). Concordance between measures of functioning, symptomatology and change: GAF, CGI-S, CGI-C and PANSS. The Second Schizophrenia International Research Society Conference, Italy.
Ulman, V., Levine, S. Z., & Rabinowitz, J. (2010). A population-based elaboration on premorbid functioning in schizophrenia during the early teenage years: Comparison, incident and onset. The Second Schizophrenia International Research Society Conference, Italy.
Werbeloff, N., Levine, S. Z., & Rabinowitz, J. (2010). Elaboration on the association between immigration and schizophrenia: a population based national study. The 23rd European College of Neuropsychopharamcology Conference. Amsterdam.
Levine, S. Z., & Rabinowitz, J. (2009). Trajectories and antecedents of treatment response over time in early episode psychosis. International Congress on Schizophrenia Research, California.
Rabinowitz, J., Levine, S. Z., Medori, R., Oosthuizen, P., Koen, L., & Emsley, R. (2008). Concordance of patient and clinical ratings regarding symptom severity and change. The 15th Biennial Winter Workshop on Schizophrenia Research, Switzerland.
Rabinowitz, J., Levine, S. Z., Medori, R., Oosthuizen, P., Koen, L., & Emsley, R. (2008). Agreement of patient and clinical ratings regarding symptom severity of psychotic illness. WPA XIV World Congress of Psychiatry, Prague.
Levine, S. Z., & Rabinowitz, J. (2008). An item response theory analysis of the positive and negative syndrome scale: psychometric recommendations to improve the appraisal of symptom severity. First Schizophrenia International Research Society Conference. Venice.
Levine, S. Z., & Rabinowitz, J. (2008). A population based examination of the role of education, age of onset and sex on the course of schizophrenia. First Schizophrenia International Research Society Conference. Venice.
Rabinowitz, J., Ingham, M., Caleo, S., Levine, S. Z. (2006). Rehospitalization rates in schizophrenia: Comprehensive Literature Review. International Society for Pharmacoeconomics & Outcomes Research, Denmark.
Rabinowitz, J., & Levine, S. Z. (2006). Findings from a 12-year population based study of first admissions (n=12,071) on (a) Age of Onset and Course of Illness and (b) Natural Course of Schizophrenia. The fourth International Meeting on the Early Phases of Mental Illness: New Perspectives in Intervention in First Episode Psychosis, Spain.
Rabinowitz, J., Levine, S. Z., & Haim R. (2006). The natural course of schizophrenia:progressive deterioration, amelioration or both? The 13th Biennial Winter Workshop on Schizophrenia Research, Davos. Switzerland.
Petrides, K. V., Jackson, C. J. & Levine, S. Z. (2002). Structural and Measurement Invariance of the Short Form of the Eysenck Personality Profiler. The 23rd Biennial Conference of the Society for Multivariate Analysis in the Behavioural Sciences, Holland.
Levine, S. Z., & Jackson, C. J. (2000). The role of personality, climate and demographic factors as antecedents of stockloss. International conference on psychology, Psychology after the year 2000, Israeli Psychological Association & University of Haifa, Israel.
Levine, S. Z., & Jackson, C. J. (2000). A lesson from work psychology in predicting cheating at university. International conference on psychology, Psychology after the year 2000, Israeli Psychological Association & University of Haifa, Israel.